To investigate how NKAIN2 expression may contribute to tumor initiation and/or clinical phenotype, we next evaluated NKAIN2 mRNA levels on several NB cell lines without copy number changes at 6p [21]–[23], in order to avoid the influence of somatic DNA alterations on gene expression. Here, NKAIN2 is linked to neuroblastoma.